Showing results (11-20 of 1,143) with videos related to
Sort By:
Pageof 115
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|June 7, 2007
AIDS in the Third World: how to stop the HIV infection?E De ClercqInternational Journal of Immunopharmacology|January 1, 1991
Chemotherapy of the acquired immune deficiency syndrome (AIDS): non-nucleoside inhibitors of the human immunodeficiency virus type 1 reverse transcriptaseE De ClercqAntiviral Research|October 1, 1998
The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infectionE De ClercqMedicinal Research Reviews|May 1, 1993
HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptaseE De ClercqAntimicrobial Agents and Chemotherapy|August 1, 1984
Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsE de ClercqBiochemical Pharmacology|October 19, 2006
Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridgeE De ClercqThe Journal of Antimicrobial Chemotherapy|July 1, 1993
Antivirals for the treatment of herpesvirus infectionsE De ClercqAdvances in Virus Research|January 1, 1993
Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interactE De ClercqBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycleE De ClercqVerhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1996
Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infectionsE De ClercqPageof 115